期刊文献+

流式细胞仪检测急性婴幼儿白血病干细胞 被引量:2

Determination of leukemia stem cells in childhood acute myeloid leukemia by flow cytometry
下载PDF
导出
摘要 背景:有关儿童急性髓细胞性白血病干细胞含量的测定及急性髓细胞性白血病患儿缓解后白血病干细胞含量与急性白血病微小残留病之间关系的研究国内外未见报道。目的:通过测定急性髓细胞性白血病干细胞或急性髓细胞性白血病干细胞-IPIC在儿童急性白血病患儿骨髓单个核细胞中的含量,研究急性髓细胞性白血病患儿缓解后白血病干细胞含量与急性白血病微小残留病水平之间的关联。方法:收集白血病患儿113例次。采用骨髓单个核细胞分离及单细胞悬液制成单细胞悬液,进行单个核细胞染色、急性髓细胞性白血病干细胞分析及根据初诊免疫表型获得白血病相关表型,并采用该白血病相关免疫表型进行单抗组合和流式细胞术测定分析。结果与结论:①初诊急性髓细胞性白血病组骨髓单个核细胞中急性髓细胞性白血病干细胞含量明显高于初诊急性淋巴细胞性白血病组和非肿瘤对照组(P均<0.017),初诊急性淋巴细胞性白血病组骨髓单个核细胞中急性髓细胞性白血病干细胞-IPIC含量显著高于非肿瘤对照组(P<0.017)。②对33例次缓解急性髓细胞性白血病患儿急性髓细胞性白血病干细胞和急性白血病微小残留病相关性分析发现,两者存在显著负相关性。结果提示,①急性髓细胞性白血病干细胞-IPIC也存在于初诊急性淋巴细胞性白血病患儿骨髓细胞中,且当急性淋巴细胞性白血病获完全缓解时急性髓细胞性白血病干细胞-IPIC含量却没有下降,但非肿瘤对照组标本中急性髓细胞性白血病干细胞-IPIC的含量极微。②急性髓细胞性白血病患儿缓解后骨髓中急性髓细胞性白血病干细胞含量和急性白血病微小残留病水平之间存在着明显的负相关。 BACKGROUND: Few studies are reported at home and abroad regarding detection of leukemia stem cell concentration in childhood acute myeloid leukemia and the correlation between leukemia stem cell level in childhood acute myeloid leukemia after remission and minimal residual disease level. OBJECTIVE: To determine leukemia stem cell level and leukemia stem cell-IPIC level in childhood acute myeloid leukemia both at initial diagnosis and at remission and correlate them to minimal residual disease level in childhood acute myeloid leukemia. METHODS: A total of 113 samples from patients with childhood acute myeloid leukemia were collected. All heparinized bone marrow mononuclear cells were separated by cell density gradient centrifugation on ficoll-hypaque solution. After washes with PBS containing 0.1% fetal calf serum, mononuclear cell suspension was prepared. Mononuclear cells were stained with fluochrome labeled monoclonal antibodies. Leukemia stem cell level was determined and leukemia-related immunophenotypes were acquired. Immunophenotype determination and flow cytometry analysis were performed. RESULTS AND CONCLUSION: Leukemia stem cell level in childhood acute myeloid leukemia group at initial diagnosis was significantly higher than that in acute lymphocytic leukaemia and non-malignancy control groups (both P&lt;0.017). The leukemia stem cell-IPIC level in childhood acute lymphocytic leukemia at initial diagnosis was significantly higher than that in the non-malignancy control group (P&lt;0.017). There was a significant negative correlation between leukemia stem cell level and minimal residual disease level in childhood acute myeloid leukemia. The results indicate that (1) the phenotypically same leukemia stem cell populations were also found in the bone marrow of patients with acute lymphocytic leukaemia at initial diagnosis, but the levels were not significantly different when complete remission was achieved. These phenotypically same populations were hardly found in the non-malignancy control group. (2) There was a significant negative correlation between leukemia stem cell level in childhood acute myeloid leukemia and minimal residual disease level in childhood acute myeloid leukemia patients after remission.
出处 《中国组织工程研究》 CAS CSCD 2013年第10期1742-1747,共6页 Chinese Journal of Tissue Engineering Research
关键词 干细胞 胚胎干细胞 急性髓细胞性白血病 急性淋巴细胞性白血病 白血病 肿瘤 白血病干细胞 急性白血病微小残留病 单个核细胞 免疫表型 CD34 CD38 stem cells embryonic stem cells acute myeloid leukemia acute lymphocytic leukemia leukemia tumor leukemia stem cells acute minimal residual disease mononuclear cells immunotype CD34 CD38
  • 相关文献

参考文献10

  • 1van Rhenen A,Feller N,Kelder A. High stem cell frequency in acute myeloid leukemia at diagnosis predicts high minimal residual disease and poor survival[J].Clinical Cancer Research,2005,(18):6520-6527.
  • 2Jordan CT,Upchurch D,Szilvassy SJ. The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells[J].Leukemia:Official Journal of the Leukemia Society of America,Leukemia Research Fund,U.K,2000,(10):1777-1784.
  • 3Guzman ML,Rossi RM,Karnischky L. The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells[J].Blood,2005,(11):4163-4169.
  • 4Guzman ML,Swiderski CF,Howard DS. Preferential induction of apoptosis for primary human leukemic stem cells[J].Proceedings of the National Academy of Sciences(USA),2002,(25):16220-16225.doi:10.1073/pnas.252462599.
  • 5Guzman ML,Jordan CT. Considerations for targeting malignant stem cells in leukemia[J].Cancer Control:Journal of the Moffitt Cancer Center,2004,(02):97-104.
  • 6Hosen N,Park CY,Tatsumi N. CD96 is a leukemic stem cell-specific marker in human acute myeloid leukemia[J].Proceedings of the National Academy of Sciences(USA),2007,(26):11008-11013.doi:10.1073/pnas.0704271104.
  • 7陆再英;钟南山.内科学[M]北京:人民卫生出版社,2008(9).
  • 8She M,Niu X,Chen X. Resistance of leukemic stem-like cells in AML cell line KG1a to natural killer cell-mediated cytotoxicity[J].Cancer Letters,2012,(02):173-179.
  • 9Park S J,Lee HW,Jeong SH. Acquisition of a BCR-ABL1 transcript in a patient with disease progression from MDS with fibrosis to AML with myelodysplasia-related changes[J].Annals of Clinical and Laboratory Science,2011,(04):379-384.
  • 10Donahue AC,Abdool AK,Gaur R. Multiplex ligation-dependent probe amplification for detection of chromosomal abnormalities in myelodysplastic syndrome and acute myeloid leukemia[J].Leukemia Research,2011,(11):1477-1483.

同被引文献6

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部